aluates Reports

$ 0.0

Automative

Global Next-Generation Immunology Drugs Market Research Report 2025

Published Date: April 2025

Report Code: QYRE-Auto-16B14214

Global Next Generation Immunology Drugs Market Research Report 2023

BUY CHAPTERS

Global Next-Generation Immunology Drugs Market Research Report 2025

Code: QYRE-Auto-16B14214

Report

April 2025

Pages:77

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

AbbVie

Johnson and Johnson

F Hoffmann La Roche Ltd

Amgen Inc

Novartis

Astellas Pharma Inc

Bristol Myers Squibb Company

Merck& Co. Inc

Eli Lilly and Company

Next-Generation Immunology Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Next-Generation Immunology Drugs Market

The global market for Next-Generation Immunology Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Next-Generation Immunology Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next-Generation Immunology Drugs.

The Next-Generation Immunology Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Next-Generation Immunology Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Next-Generation Immunology Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Next-Generation Immunology Drugs Market Report

Report Metric	Details
Report Name	Next-Generation Immunology Drugs Market
CAGR	5%
Segment by Type	Cell Therapy Small Molecule Drug Others
Segment by Application	Hospital Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer Inc, Abbvie Inc., Johnson and Johnson, F. Hoffmann-La Roche Ltd., Amgen Inc., Novartis AG, Astellas Pharma Inc., Bristol-Myers Squibb Company, Merck & Co., Inc., Eli Lilly and Company
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Next-Generation Immunology Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Next-Generation Immunology Drugs Market report?

Ans: The main players in the Next-Generation Immunology Drugs Market are Pfizer Inc, Abbvie Inc., Johnson and Johnson, F. Hoffmann-La Roche Ltd., Amgen Inc., Novartis AG, Astellas Pharma Inc., Bristol-Myers Squibb Company, Merck & Co., Inc., Eli Lilly and Company

What are the Application segmentation covered in the Next-Generation Immunology Drugs Market report?

Ans: The Applications covered in the Next-Generation Immunology Drugs Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Next-Generation Immunology Drugs Market report?

Ans: The Types covered in the Next-Generation Immunology Drugs Market report are Cell Therapy, Small Molecule Drug, Others

Recommended Reports

Immunology Drugs

Diagnostics & Screening

Pharma Services

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Next-Generation Immunology Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Cell Therapy

1.2.3 Small Molecule Drug

1.2.4 Others

1.3 Market by Application

1.3.1 Global Next-Generation Immunology Drugs Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Next-Generation Immunology Drugs Market Perspective (2020-2031)

2.2 Global Next-Generation Immunology Drugs Growth Trends by Region

2.2.1 Global Next-Generation Immunology Drugs Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Next-Generation Immunology Drugs Historic Market Size by Region (2020-2025)

2.2.3 Next-Generation Immunology Drugs Forecasted Market Size by Region (2026-2031)

2.3 Next-Generation Immunology Drugs Market Dynamics

2.3.1 Next-Generation Immunology Drugs Industry Trends

2.3.2 Next-Generation Immunology Drugs Market Drivers

2.3.3 Next-Generation Immunology Drugs Market Challenges

2.3.4 Next-Generation Immunology Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Next-Generation Immunology Drugs Players by Revenue

3.1.1 Global Top Next-Generation Immunology Drugs Players by Revenue (2020-2025)

3.1.2 Global Next-Generation Immunology Drugs Revenue Market Share by Players (2020-2025)

3.2 Global Next-Generation Immunology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Next-Generation Immunology Drugs Revenue

3.4 Global Next-Generation Immunology Drugs Market Concentration Ratio

3.4.1 Global Next-Generation Immunology Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Next-Generation Immunology Drugs Revenue in 2024

3.5 Global Key Players of Next-Generation Immunology Drugs Head office and Area Served

3.6 Global Key Players of Next-Generation Immunology Drugs, Product and Application

3.7 Global Key Players of Next-Generation Immunology Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Next-Generation Immunology Drugs Breakdown Data by Type

4.1 Global Next-Generation Immunology Drugs Historic Market Size by Type (2020-2025)

4.2 Global Next-Generation Immunology Drugs Forecasted Market Size by Type (2026-2031)

5 Next-Generation Immunology Drugs Breakdown Data by Application

5.1 Global Next-Generation Immunology Drugs Historic Market Size by Application (2020-2025)

5.2 Global Next-Generation Immunology Drugs Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Next-Generation Immunology Drugs Market Size (2020-2031)

6.2 North America Next-Generation Immunology Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Next-Generation Immunology Drugs Market Size by Country (2020-2025)

6.4 North America Next-Generation Immunology Drugs Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Next-Generation Immunology Drugs Market Size (2020-2031)

7.2 Europe Next-Generation Immunology Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Next-Generation Immunology Drugs Market Size by Country (2020-2025)

7.4 Europe Next-Generation Immunology Drugs Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Next-Generation Immunology Drugs Market Size (2020-2031)

8.2 Asia-Pacific Next-Generation Immunology Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Next-Generation Immunology Drugs Market Size by Region (2020-2025)

8.4 Asia-Pacific Next-Generation Immunology Drugs Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Next-Generation Immunology Drugs Market Size (2020-2031)

9.2 Latin America Next-Generation Immunology Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Next-Generation Immunology Drugs Market Size by Country (2020-2025)

9.4 Latin America Next-Generation Immunology Drugs Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Next-Generation Immunology Drugs Market Size (2020-2031)

10.2 Middle East & Africa Next-Generation Immunology Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Next-Generation Immunology Drugs Market Size by Country (2020-2025)

10.4 Middle East & Africa Next-Generation Immunology Drugs Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer Inc

11.1.1 Pfizer Inc Company Details

11.1.2 Pfizer Inc Business Overview

11.1.3 Pfizer Inc Next-Generation Immunology Drugs Introduction

11.1.4 Pfizer Inc Revenue in Next-Generation Immunology Drugs Business (2020-2025)

11.1.5 Pfizer Inc Recent Development

11.2 Abbvie Inc.

11.2.1 Abbvie Inc. Company Details

11.2.2 Abbvie Inc. Business Overview

11.2.3 Abbvie Inc. Next-Generation Immunology Drugs Introduction

11.2.4 Abbvie Inc. Revenue in Next-Generation Immunology Drugs Business (2020-2025)

11.2.5 Abbvie Inc. Recent Development

11.3 Johnson and Johnson

11.3.1 Johnson and Johnson Company Details

11.3.2 Johnson and Johnson Business Overview

11.3.3 Johnson and Johnson Next-Generation Immunology Drugs Introduction

11.3.4 Johnson and Johnson Revenue in Next-Generation Immunology Drugs Business (2020-2025)

11.3.5 Johnson and Johnson Recent Development

11.4 F. Hoffmann-La Roche Ltd.

11.4.1 F. Hoffmann-La Roche Ltd. Company Details

11.4.2 F. Hoffmann-La Roche Ltd. Business Overview

11.4.3 F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Introduction

11.4.4 F. Hoffmann-La Roche Ltd. Revenue in Next-Generation Immunology Drugs Business (2020-2025)

11.4.5 F. Hoffmann-La Roche Ltd. Recent Development

11.5 Amgen Inc.

11.5.1 Amgen Inc. Company Details

11.5.2 Amgen Inc. Business Overview

11.5.3 Amgen Inc. Next-Generation Immunology Drugs Introduction

11.5.4 Amgen Inc. Revenue in Next-Generation Immunology Drugs Business (2020-2025)

11.5.5 Amgen Inc. Recent Development

11.6 Novartis AG

11.6.1 Novartis AG Company Details

11.6.2 Novartis AG Business Overview

11.6.3 Novartis AG Next-Generation Immunology Drugs Introduction

11.6.4 Novartis AG Revenue in Next-Generation Immunology Drugs Business (2020-2025)

11.6.5 Novartis AG Recent Development

11.7 Astellas Pharma Inc.

11.7.1 Astellas Pharma Inc. Company Details

11.7.2 Astellas Pharma Inc. Business Overview

11.7.3 Astellas Pharma Inc. Next-Generation Immunology Drugs Introduction

11.7.4 Astellas Pharma Inc. Revenue in Next-Generation Immunology Drugs Business (2020-2025)

11.7.5 Astellas Pharma Inc. Recent Development

11.8 Bristol-Myers Squibb Company

11.8.1 Bristol-Myers Squibb Company Company Details

11.8.2 Bristol-Myers Squibb Company Business Overview

11.8.3 Bristol-Myers Squibb Company Next-Generation Immunology Drugs Introduction

11.8.4 Bristol-Myers Squibb Company Revenue in Next-Generation Immunology Drugs Business (2020-2025)

11.8.5 Bristol-Myers Squibb Company Recent Development

11.9 Merck & Co., Inc.

11.9.1 Merck & Co., Inc. Company Details

11.9.2 Merck & Co., Inc. Business Overview

11.9.3 Merck & Co., Inc. Next-Generation Immunology Drugs Introduction

11.9.4 Merck & Co., Inc. Revenue in Next-Generation Immunology Drugs Business (2020-2025)

11.9.5 Merck & Co., Inc. Recent Development

11.10 Eli Lilly and Company

11.10.1 Eli Lilly and Company Company Details

11.10.2 Eli Lilly and Company Business Overview

11.10.3 Eli Lilly and Company Next-Generation Immunology Drugs Introduction

11.10.4 Eli Lilly and Company Revenue in Next-Generation Immunology Drugs Business (2020-2025)

11.10.5 Eli Lilly and Company Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Pfizer Inc

AbbVie

Johnson and Johnson

F Hoffmann La Roche Ltd

Amgen Inc

Novartis

Astellas Pharma Inc

Bristol Myers Squibb Company

Merck& Co. Inc

Eli Lilly and Company

List of Tables

Table 1. Global Next-Generation Immunology Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Cell Therapy

Table 3. Key Players of Small Molecule Drug

Table 4. Key Players of Others

Table 5. Global Next-Generation Immunology Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Next-Generation Immunology Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Next-Generation Immunology Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Next-Generation Immunology Drugs Market Share by Region (2020-2025)

Table 9. Global Next-Generation Immunology Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Next-Generation Immunology Drugs Market Share by Region (2026-2031)

Table 11. Next-Generation Immunology Drugs Market Trends

Table 12. Next-Generation Immunology Drugs Market Drivers

Table 13. Next-Generation Immunology Drugs Market Challenges

Table 14. Next-Generation Immunology Drugs Market Restraints

Table 15. Global Next-Generation Immunology Drugs Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Next-Generation Immunology Drugs Market Share by Players (2020-2025)

Table 17. Global Top Next-Generation Immunology Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next-Generation Immunology Drugs as of 2024)

Table 18. Ranking of Global Top Next-Generation Immunology Drugs Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Next-Generation Immunology Drugs Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Next-Generation Immunology Drugs, Headquarters and Area Served

Table 21. Global Key Players of Next-Generation Immunology Drugs, Product and Application

Table 22. Global Key Players of Next-Generation Immunology Drugs, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Next-Generation Immunology Drugs Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Next-Generation Immunology Drugs Revenue Market Share by Type (2020-2025)

Table 26. Global Next-Generation Immunology Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Next-Generation Immunology Drugs Revenue Market Share by Type (2026-2031)

Table 28. Global Next-Generation Immunology Drugs Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Next-Generation Immunology Drugs Revenue Market Share by Application (2020-2025)

Table 30. Global Next-Generation Immunology Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Next-Generation Immunology Drugs Revenue Market Share by Application (2026-2031)

Table 32. North America Next-Generation Immunology Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Next-Generation Immunology Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Next-Generation Immunology Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Next-Generation Immunology Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Next-Generation Immunology Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Next-Generation Immunology Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Next-Generation Immunology Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Next-Generation Immunology Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Next-Generation Immunology Drugs Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Next-Generation Immunology Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Next-Generation Immunology Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Next-Generation Immunology Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Next-Generation Immunology Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Next-Generation Immunology Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Next-Generation Immunology Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 47. Pfizer Inc Company Details

Table 48. Pfizer Inc Business Overview

Table 49. Pfizer Inc Next-Generation Immunology Drugs Product

Table 50. Pfizer Inc Revenue in Next-Generation Immunology Drugs Business (2020-2025) & (US$ Million)

Table 51. Pfizer Inc Recent Development

Table 52. Abbvie Inc. Company Details

Table 53. Abbvie Inc. Business Overview

Table 54. Abbvie Inc. Next-Generation Immunology Drugs Product

Table 55. Abbvie Inc. Revenue in Next-Generation Immunology Drugs Business (2020-2025) & (US$ Million)

Table 56. Abbvie Inc. Recent Development

Table 57. Johnson and Johnson Company Details

Table 58. Johnson and Johnson Business Overview

Table 59. Johnson and Johnson Next-Generation Immunology Drugs Product

Table 60. Johnson and Johnson Revenue in Next-Generation Immunology Drugs Business (2020-2025) & (US$ Million)

Table 61. Johnson and Johnson Recent Development

Table 62. F. Hoffmann-La Roche Ltd. Company Details

Table 63. F. Hoffmann-La Roche Ltd. Business Overview

Table 64. F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Product

Table 65. F. Hoffmann-La Roche Ltd. Revenue in Next-Generation Immunology Drugs Business (2020-2025) & (US$ Million)

Table 66. F. Hoffmann-La Roche Ltd. Recent Development

Table 67. Amgen Inc. Company Details

Table 68. Amgen Inc. Business Overview

Table 69. Amgen Inc. Next-Generation Immunology Drugs Product

Table 70. Amgen Inc. Revenue in Next-Generation Immunology Drugs Business (2020-2025) & (US$ Million)

Table 71. Amgen Inc. Recent Development

Table 72. Novartis AG Company Details

Table 73. Novartis AG Business Overview

Table 74. Novartis AG Next-Generation Immunology Drugs Product

Table 75. Novartis AG Revenue in Next-Generation Immunology Drugs Business (2020-2025) & (US$ Million)

Table 76. Novartis AG Recent Development

Table 77. Astellas Pharma Inc. Company Details

Table 78. Astellas Pharma Inc. Business Overview

Table 79. Astellas Pharma Inc. Next-Generation Immunology Drugs Product

Table 80. Astellas Pharma Inc. Revenue in Next-Generation Immunology Drugs Business (2020-2025) & (US$ Million)

Table 81. Astellas Pharma Inc. Recent Development

Table 82. Bristol-Myers Squibb Company Company Details

Table 83. Bristol-Myers Squibb Company Business Overview

Table 84. Bristol-Myers Squibb Company Next-Generation Immunology Drugs Product

Table 85. Bristol-Myers Squibb Company Revenue in Next-Generation Immunology Drugs Business (2020-2025) & (US$ Million)

Table 86. Bristol-Myers Squibb Company Recent Development

Table 87. Merck & Co., Inc. Company Details

Table 88. Merck & Co., Inc. Business Overview

Table 89. Merck & Co., Inc. Next-Generation Immunology Drugs Product

Table 90. Merck & Co., Inc. Revenue in Next-Generation Immunology Drugs Business (2020-2025) & (US$ Million)

Table 91. Merck & Co., Inc. Recent Development

Table 92. Eli Lilly and Company Company Details

Table 93. Eli Lilly and Company Business Overview

Table 94. Eli Lilly and Company Next-Generation Immunology Drugs Product

Table 95. Eli Lilly and Company Revenue in Next-Generation Immunology Drugs Business (2020-2025) & (US$ Million)

Table 96. Eli Lilly and Company Recent Development

Table 97. Research Programs/Design for This Report

Table 98. Key Data Information from Secondary Sources

Table 99. Key Data Information from Primary Sources

Table 100. Authors List of This Report

List of Figures

Figure 1. Next-Generation Immunology Drugs Picture

Figure 2. Global Next-Generation Immunology Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Next-Generation Immunology Drugs Market Share by Type: 2024 VS 2031

Figure 4. Cell Therapy Features

Figure 5. Small Molecule Drug Features

Figure 6. Others Features

Figure 7. Global Next-Generation Immunology Drugs Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Next-Generation Immunology Drugs Market Share by Application: 2024 VS 2031

Figure 9. Hospital Case Studies

Figure 10. Clinic Case Studies

Figure 11. Others Case Studies

Figure 12. Next-Generation Immunology Drugs Report Years Considered

Figure 13. Global Next-Generation Immunology Drugs Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Next-Generation Immunology Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Next-Generation Immunology Drugs Market Share by Region: 2024 VS 2031

Figure 16. Global Next-Generation Immunology Drugs Market Share by Players in 2024

Figure 17. Global Top Next-Generation Immunology Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next-Generation Immunology Drugs as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Next-Generation Immunology Drugs Revenue in 2024

Figure 19. North America Next-Generation Immunology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Next-Generation Immunology Drugs Market Share by Country (2020-2031)

Figure 21. United States Next-Generation Immunology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Next-Generation Immunology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Next-Generation Immunology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Next-Generation Immunology Drugs Market Share by Country (2020-2031)

Figure 25. Germany Next-Generation Immunology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Next-Generation Immunology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Next-Generation Immunology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Next-Generation Immunology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Next-Generation Immunology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Next-Generation Immunology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Next-Generation Immunology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Next-Generation Immunology Drugs Market Share by Region (2020-2031)

Figure 33. China Next-Generation Immunology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Next-Generation Immunology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Next-Generation Immunology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Next-Generation Immunology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Next-Generation Immunology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Next-Generation Immunology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Next-Generation Immunology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Next-Generation Immunology Drugs Market Share by Country (2020-2031)

Figure 41. Mexico Next-Generation Immunology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Next-Generation Immunology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Next-Generation Immunology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Next-Generation Immunology Drugs Market Share by Country (2020-2031)

Figure 45. Turkey Next-Generation Immunology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Next-Generation Immunology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Next-Generation Immunology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Pfizer Inc Revenue Growth Rate in Next-Generation Immunology Drugs Business (2020-2025)

Figure 49. Abbvie Inc. Revenue Growth Rate in Next-Generation Immunology Drugs Business (2020-2025)

Figure 50. Johnson and Johnson Revenue Growth Rate in Next-Generation Immunology Drugs Business (2020-2025)

Figure 51. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Next-Generation Immunology Drugs Business (2020-2025)

Figure 52. Amgen Inc. Revenue Growth Rate in Next-Generation Immunology Drugs Business (2020-2025)

Figure 53. Novartis AG Revenue Growth Rate in Next-Generation Immunology Drugs Business (2020-2025)

Figure 54. Astellas Pharma Inc. Revenue Growth Rate in Next-Generation Immunology Drugs Business (2020-2025)

Figure 55. Bristol-Myers Squibb Company Revenue Growth Rate in Next-Generation Immunology Drugs Business (2020-2025)

Figure 56. Merck & Co., Inc. Revenue Growth Rate in Next-Generation Immunology Drugs Business (2020-2025)

Figure 57. Eli Lilly and Company Revenue Growth Rate in Next-Generation Immunology Drugs Business (2020-2025)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Immune Drugs Market Insights Forecast to 2030

Next Generation Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cancers Immunotherapy Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Autoimmune Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Clinical Trials of Drugs and Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global TNF IL Cytokines Market Insights Forecast to 2030

Tumor Immunotherapy Market

Global Autoimmune Diseases Treatment Market Research Report 2024

Prescription Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Generic Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Immunodiagnostic System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

New Drug Research and Development Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Systemic Infection Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

High density Multiplexed Diagnostic Assays Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Novel Drug Delivery Systems for Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Influenza Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaccines Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaccine Administration Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Super Generic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions